Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$59,258,143
-$67,699,841 QoQ
Shares Held
977,051
-58.5% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $774,861,209 across 9 Drug Manufacturers - General names. BMY ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,152,528 | $299,997,827 | |
| 2 | NVS |
Novartis AG
|
1,111,833 | $169,832,490 | |
| 3 | NVO |
Novo Nordisk A S
|
3,397,121 | $124,844,196 | |
| 4 | LLY |
ELI LILLY & Co
|
71,788 | $66,028,448 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
977,051 | $59,258,143 | |
| 6 | BIIB |
Biogen Inc.
|
203,396 | $37,288,588 | |
| 7 | GSK |
GSK plc
|
311,292 | $17,180,205 | |
| 8 | AMRN |
Amarin Corp Plc\Uk
|
19,256 | $278,441 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,258,143 | 977,051 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $126,957,984 | 2,353,689 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $165,412,773 | 3,667,689 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $161,141,646 | 3,481,133 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $126,501,371 | 2,074,133 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $59,983,746 | 1,060,533 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $47,007,756 | 908,538 | Shares | Sole | 2024-11-13 | |
| 2023-12-31 | $124,794,437 | 2,432,166 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $59,714,686 | 1,028,854 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $77,341,130 | 1,209,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $79,311,433 | 1,144,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $47,285,540 | 657,200 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $63,295,386 | 822,018 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $192,312,235 | 2,633,332 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $314,293,007 | 5,040,786 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $421,345,132 | 7,120,925 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $488,181,908 | 7,305,925 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $440,154,165 | 6,972,187 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,146,353,478 | 18,480,630 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,843,452,783 | 30,576,427 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,557,631,302 | 43,497,131 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,678,400,267 | 65,992,111 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||